AXIAL THERAPEUTICS Trademark

Trademark Overview


On Monday, September 28, 2020, a trademark application was filed for AXIAL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AXIAL THERAPEUTICS trademark a serial number of 90217689. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by Axial Biotherapeutics, Inc.. The AXIAL THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids

Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids

Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic or microbe-targeted pharmaceuticals

Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others
axial therapeutics

General Information


Serial Number90217689
Word MarkAXIAL THERAPEUTICS
Filing DateMonday, September 28, 2020
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7355827
Registration DateTuesday, April 9, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 23, 2021

Trademark Statements


Description of MarkThe mark consists of eight circles, each connected to a central donut circle by two horizontal lines at the left and right, one shorter vertical line at the top, one longer vertical line at the bottom, one short diagonal line at the lower-left, one longer diagonal line at the upper-left, one slightly longer diagonal line at the upper-right, and one longer diagonal line at the lower right. To the right of this is the stacked stylized wording "AXIAL THERAPEUTICS" where "AXIAL" is in larger-sized font and "THERAPEUTICS" is in smaller-sized font.
Goods and ServicesProbiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
Goods and ServicesChemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
Goods and ServicesProviding medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic or microbe-targeted pharmaceuticals
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesProviding medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, November 10, 2020
Primary Code001
First Use Anywhere DateSaturday, October 1, 2022
First Use In Commerce DateSaturday, October 1, 2022

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 10, 2020
Primary Code005
First Use Anywhere DateMonday, December 20, 2021
First Use In Commerce DateMonday, December 20, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 10, 2020
Primary Code042
First Use Anywhere DateSunday, October 24, 2021
First Use In Commerce DateSunday, October 24, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 10, 2020
Primary Code044
First Use Anywhere DateSunday, October 24, 2021
First Use In Commerce DateSunday, October 24, 2021

Trademark Owner History


Party NameAXIAL THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWOBURN, MA 01801

Party NameAXIAL THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWOBURN, MA 01801

Party NameAXIAL THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressWOBURN, MA 01801

Party NameAxial Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, March 7, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 6, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 26, 2024ASSIGNED TO LIE
Wednesday, October 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 18, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 21, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, June 21, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, April 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2023NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2023SU - NON-FINAL ACTION - WRITTEN
Monday, March 6, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, February 17, 2023USE AMENDMENT FILED
Monday, March 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 17, 2023TEAS STATEMENT OF USE RECEIVED
Friday, January 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2023SOU EXTENSION 2 GRANTED
Wednesday, January 11, 2023SOU EXTENSION 2 FILED
Wednesday, January 11, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 17, 2022SOU EXTENSION 1 GRANTED
Friday, June 17, 2022SOU EXTENSION 1 FILED
Friday, June 17, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 24, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 22, 2021NON-FINAL ACTION E-MAILED
Monday, March 22, 2021NON-FINAL ACTION WRITTEN
Thursday, February 25, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, February 25, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 25, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, February 25, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, February 19, 2021ASSIGNED TO EXAMINER
Wednesday, November 11, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, November 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 1, 2020NEW APPLICATION ENTERED